| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avenue Therapeutics, Inc. (ATXI) has 0 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. ATXI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2019 | Herskowitz Neil | Director | Buy | 650 | $5.91 | $3,841.50 | +0.8% | |
| Jan 29, 2019 | Herskowitz Neil | Director | Buy | 10,000 | $5.90 | $58,998.71 | +7.4% | |
| Dec 10, 2018 | Paley Jeffrey59 | Director | Buy | 15,000 | $5.24 | $78,554.00 | +10.8% | |
| Jun 8, 2018 | Rosenwald Lindsay A Md64 | Director | Buy | 5,234 | $4.34 | $22,715.56 | +26.2% | |
| Apr 25, 2018 | Herskowitz Neil | Director | Buy | 1,000 | $3.80 | $3,800.00 | +1.9% | |
| Oct 17, 2017 | Herskowitz Neil | Director | Buy | 1,000 | $5.01 | $5,010.00 | +2.0% | |
| Oct 9, 2017 | Herskowitz Neil | Director | Buy | 500 | $5.24 | $2,620.00 | +1.0% | |
| Oct 9, 2017 | Rosenwald Lindsay A Md64 | Director | Buy | 10,000 | $5.58 | $55,817.00 | +17.7% |